ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 202% based on the discounted cash flow analysis.
| Market cap | $2.08 Billion |
|---|---|
| Enterprise Value | $2.02 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.12 |
| Outstanding Shares | 29,622,101 |
| P/E Ratio | -47.88 |
|---|---|
| PEG | 135.31 |
| Price to Sales | 10.34 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.79 |
| Enterprise Value to EBIT | -67.67 |
| Enterprise Value to Net Income | -47 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1527▼ 152.74% |
|---|---|
| Total Calls | 2,797,500▲ 121.43% |
| Total Puts | 427,100▼ 79.88% |
Holdings and activity of institutional investors.
| Ownership % | 90.32%▲ 0.99% |
|---|---|
| Total Invested | $1.52B▼ 21.21% |
| Investors Holding | 187▼ 1.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...